Scout

36C25026Q0379

L076--VISN 10 - Online Clinical Drug Information

VETERANS AFFAIRS, DEPARTMENT OF > VETERANS AFFAIRS, DEPARTMENT OF > 250-NETWORK CONTRACT OFFICE 10 (36C250)

Archived
Actions
Open SAM.gov
Notice Type Combined Synopsis/Solicitation
Due 2026-04-08
Posted 2026-03-30
NAICS 513210
PSC L076
Set-aside Service-Disabled Veteran-Owned Small Business Set Aside
Scout Score 6

Quick analysis

Solicitation 36C25026Q0379 is an SDVOSB set-aside for a VISN 10 Online Clinical Drug Information SaaS subscription with virtual training, 24/7 support, and monthly usage reporting.

Trace Systems is not an SDVOSB (per company profile) and the scope is a clinical drug reference platform (NAICS 513210), which is outside Trace’s core capabilities and past performance lanes.

Amendment 0003 confirms the SDVOSB set‑aside and extends the deadline to 2026-04-08, and emphasizes Limitations on Subcontracting applicability to SaaS. Government identified SDVOSB resellers in market research, signaling reseller prime dynamics unrelated to Trace’s offerings.

One amendment file (0004) is unreadable and the base RFQ is only partially extracted, but these gaps do not change the clear set‑aside ineligibility and poor technical fit.

Scope summary

  • Provide an online clinical drug information SaaS platform for VISN 10 with comprehensive, evidence-based content (medication monographs, BBWs, REMS, IV compatibility, interactions, calculators, patient education).
  • Deliver 24/7 customer support (phone/email) and virtual training only (up to four sessions/year); no on-site training.
  • Provide a Quality Control Plan and monthly usage reports (sessions, searches, document retrievals) to the VISN POC.
  • Ensure 99% uptime (excluding scheduled maintenance) and fast search performance (~2 seconds) under standard conditions.
  • Meet Section 508 accessibility and provide VPAT/ACR.
  • Offer 45-day temporary system access for evaluation; any trial license agreement must be at no cost and submitted to the CO before the deadline.
  • Comply with VA SDVOSB set‑aside and Limitations on Subcontracting rules applicable to SaaS (FAR 52.219-14; VAAR 852.219-75).
  • Base + 4 option years; services largely delivered remotely to VA facilities across IN/MI/OH; no VA PII/PHI handled.

Dimension scores

Total - 6/100
Technical Fit - 2/20

Scope is a clinical drug information SaaS (NAICS 513210) with specialized medical content, uptime SLAs, and Section 508 requirements. This is outside Trace’s stated core capabilities (SATCOM, CDS, JADC2, edge compute, IT O&M). Evidence: RFQ/Amendments describing online clinical drug database, content features, and SaaS access.

Past Performance - 1/20

No cited Trace past performance with VA clinical drug information or healthcare SaaS. Company profile lists DoD/Space/DISA-centric work (MPE-S, ABMS, EMSS EPCC, etc.), not clinical content services. Evidence: company_profile.txt past performance; RFQ requires PPQ but no relevant Trace examples provided.

Vehicles / Contract Access - 0/10

This is a stand-alone SDVOSB set-aside RFQ; not on a Trace prime vehicle, and Trace is ineligible to prime as a non‑SDVOSB. Evidence: RFQ and amendments show SDVOSB set‑aside; company_profile indicates Trace is not SDVOSB.

Competitive Position - 0/15

Clear disqualifier: SDVOSB set‑aside and domain is clinical drug content SaaS typically offered by specialized vendors. Government found SDVOSB resellers planning to prime. Trace has no differentiator here. Evidence: Amendment 0003 market research note; set‑aside status in RFQ.

Risk - 3/15

Very high pursuit risk for Trace due to set‑aside ineligibility and lack of domain capability; any role would require teaming as a minor sub to an SDVOSB reseller with the OEM, offering limited control. Evidence: SDVOSB set‑aside; SaaS LOS rules in Amendment 0003.

Strategic Value - 0/10

Does not advance Trace’s target agencies or core lanes and offers no synergy with SATCOM/CDS/JADC2/edge compute. Low potential value even as a sub on a clinical SaaS subscription. Evidence: company_profile targets (DoD/Space/DISA) vs. VA clinical content subscription scope.

Compliance - 0/10

Set‑aside mismatch: solicitation is SDVOSB-only; Trace is not SDVOSB per company profile. This is a likely disqualifier. Evidence: RFQ and amendments state SDVOSB set‑aside; company_profile confirms Trace not eligible.

Concerns

  • Set‑aside ineligibility (Trace is not SDVOSB) is a primary blocker.
  • Outside Trace’s core technical and mission lanes; minimal value-add even as a subcontractor.
  • SaaS Limitations on Subcontracting and reseller structure create compliance verification risk post‑award (VAAR 819.7004(e)).
  • Short schedule and trial access requirement prior to deadline may strain OEM coordination for bidders.
  • Unreadable Amendment 0004 may include changes not reflected in reviewed files (limited confidence on any late updates).

Teaming opportunities

  • An SDVOSB prime contractor is required to access this opportunity.
  • Access to an OEM clinical drug information platform (e.g., established medical content publisher) is necessary; Trace does not provide this capability.
  • Healthcare IT/clinical informatics SMEs to address content, training, and compliance details.

Competitive position

  • Not applicable for Trace as a prime due to SDVOSB restriction; minimal to no differentiated value as a sub on a clinical content SaaS.

Bid/No bid factors

  • Set‑aside type mismatch (SDVOSB) — Trace is ineligible to prime (automatic review flag per scoring guidance).
  • Scope is clinical drug information SaaS, outside Trace’s core capabilities and targets.
  • Amendment 0003 emphasizes SaaS LOS accounting, complicating reseller compositions; Government expects SDVOSB reseller primes.
  • Amendment 0004 is unreadable; potential unverified requirement changes.

Documents

Download all
26Q0379 - PPQ - Vendor Name.pdf Download
Summary

VA Past Performance Questionnaire (6 pages) tailored to RFQ 36C25026Q0379 (VHA V10 Online Drug Database). It is a template for references to complete, includes solicitation-specific submission instructions (recipient email, subject line, and a stated due date), and VA rating definitions and evaluation criteria across quality, schedule, customer satisfaction, management, cost, safety, and general performance.

  • Document is a Past Performance Questionnaire (PPQ) for RFQ 36C25026Q0379 — VHA V10 Online Drug Database (6-page VA template).
  • Requests Past Performance Reference entries (Past Performance Reference No. 1-5) and detailed contract information (contract number, agency, contract type, award date, original/final price) — enables assessment of contract dollar size and relevance.
  • Explicit submission instructions: references asked to submit completed PPQ directly to Joshua.Kovar@VA.gov with subject line “26Q0379 - PPQ , [ Name of Offerer]”.
  • A deadline for PPQ submissions is printed as 1:30 PM EST on April 01, 2026 (note: this is the date shown in the PPQ instructions).
  • VA reserves the right to verify information on the form — indicates government will validate references and may contact COs/technical reps provided.
  • Rating scheme and definitions included (Exceptional, Very Good, Satisfactory, Marginal, Unsatisfactory, Not Applicable) and rating criteria categories: Quality; Schedule/Timeliness; Customer Satisfaction; Management/Personnel/Labor; Cost/Financial Management; Safety/Security; General — tells what performance dimensions the government will weigh.
  • Form requests reference and CO contact blocks (names, emails, phone numbers) and narrative comments — supports gathering verifiable past performance details and qualitative comments.
36C25026Q0379 0001.docx Download
Summary

Solicitation amendment for VISN 10 Online Clinical Drug Information that revises the Quality Control & Support section: requires a 24/7 helpdesk, virtual training (up to four sessions/year), monthly usage reporting, and states there will be no on‑site training with all training costs included in the firm‑fixed price. The document lists POC (Josh Kovar), NAICS 513210, set‑aside SDVOSBC, place of performance across VISN 10 VA facilities in Indiana, Michigan, and Ohio, and provides authorized bed counts by facility (excluding CLC/ domiciliary beds).

  • Set‑aside: SDVOSBC (Service‑Disabled Veteran‑Owned Small Business Set Aside)
  • NAICS: 513210
  • Place of Performance: VHA VISN 10 VA Medical Centers; VA facilities across Indiana, Michigan, and Ohio
  • POC: Contracting Officer Josh Kovar; email Joshua.Kovar@va.gov (questions to be emailed before QA deadline)
  • Quality Control & Support requirements updated to: Quality Control Plan; Customer Support & Training (24/7 helpdesk phone/email); training approach and documentation roadmap (PWS §11 deliverables)
  • Training: virtual only; up to four virtual sessions per year; trainings scheduled at VISN POC direction
  • Cost treatment: “There will be no on‑site training. All costs for training and any other deliverables shall be fully burdened in the firm‑fixed price quoted for the specified period.”
  • Usage reporting: monthly usage reports required (sessions, searches, document retrievals) to VISN POC (PWS §11)
  • Solicitation number: 36C25026Q0379; Product Service Code: L076
  • Authorized bed counts provided per VISN 10 facility (explicitly excludes CLC/nursing home and domiciliary beds)
36C25026Q0379 0002.docx Download
Summary

Solicitation amendment (Q&A) for 36C25026Q0379 "VISN 10 - Online Clinical Drug Information" that provides answers to industry questions, identifies Josh Kovar as the Contracting Officer POC, and instructs that any trial license agreements for the 45-day temporary system access must be submitted to the Contracting Officer and provided at no cost to the Government. The document lists solicitation metadata (Set-Aside: SDVOSBC; NAICS: 513210; PSC: L076), place of performance as VISN 10 VA Medical Centers across Indiana, Michigan, and Ohio, and shows a response date/time of 04-01-2026 13:30 ET (note: opportunity metadata elsewhere shows 04-08-2026).

  • Solicitation number: 36C25026Q0379; subject: VISN 10 - Online Clinical Drug Information (amendment / Q&A).
  • Set-aside: SDVOSBC (Service-Disabled Veteran-Owned Small Business).
  • NAICS: 513210; PSC: L076.
  • Response date/time listed in this document: 04-01-2026 13:30 Eastern Time (discrepancy vs. external metadata 04-08-2026).
  • Place of performance: US Department of Veterans Affairs VHA VISN 10 VA Medical Centers — VA facilities across Indiana, Michigan and Ohio.
  • Contracting office address: Network Contracting Office (NCO 10), 3140 Governor’s Place Blvd. Suite 210, Kettering OH 45409-1337.
  • Contracting Officer POC: Josh Kovar — Joshua.Kovar@va.gov; phone: 937-268-6511; questions must be emailed to POC before QA deadline.
  • Operational requirement: 45-day Temporary System Access for evaluating the Comprehensive Drug Reference Database; any Trial License Agreement must be provided directly to the Contracting Officer.
  • Trial license agreement requirement: must clearly state trial access is provided at no cost to the Government and be submitted prior to the solicitation deadline so evaluators can access the database immediately after the deadline.
  • Archive: 60 days after the response date; Recovery Act funds: N.
36C25026Q0379 0003.docx Download
Summary

Amendment 0003 to solicitation 36C25026Q0379 (VISN 10 - Online Clinical Drug Information) extends the quote deadline to 04-08-2026 13:30 ET and provides responses to industry Q&A. The amendment clarifies SDVOSB subcontracting rules for SaaS under FAR 52.219‑14 and VAAR 852.219‑75 (specifically that primary SaaS costs—including licensing, hosting, implementation, and training—count toward the Government payment limitation), notes the Government identified SDVOSB resellers during market research, and states compliance will be evaluated per offer and may be audited post‑award. Place of performance is VHA VISN 10 VA Medical Centers across Indiana, Michigan, and Ohio; contracting POC is Joshua Kovar (Network Contracting Office 10, Kettering, OH).

  • Set‑aside: SDVOSBC (Service‑Disabled Veteran‑Owned Small Business) — solicitation restricted to SDVOSBs
  • NAICS: 513210 (software publishing/SaaS) and PSC: L076
  • Response deadline extended to 2026‑04‑08 13:30 ET; submission via Joshua.Kovar@va.gov
  • Place of performance: VHA VISN 10 VA Medical Centers across Indiana, Michigan, and Ohio (multi‑state CONUS locations)
  • Contracting office: Network Contracting Office 10, 3140 Governor’s Place Blvd., Kettering, OH; POC: Josh Kovar, Joshua.Kovar@va.gov, 937‑268‑6511
  • Scope: Acquisition is for an Online Clinical Drug Information SaaS platform (solicitation emphasizes SaaS cost elements)
  • SaaS licensing, hosting, implementation, and training are counted as 'amount paid by the Government' for FAR 52.219‑14(e)(1) and VAAR 852.219‑75(a)(1)(i), so they count toward the 50% subcontracting limit for SDVOSB primes
  • Market research found two or more SDVOSBs indicating they would bid as reseller primes (signals potential reseller/teaming market and that original developers may remain operators)
  • Government will not pre‑determine Limitations on Subcontracting compliance and may request compliance reports post‑award per VAAR 819‑7004(e) and FAR 52.219‑14(d) (reporting / verification risk)
  • Amendment addresses industry questions (including a pending clarification on operational CLC/domiciliary bed counts) and confirms solicitation remains time‑sensitive with short turnaround to deadline
36C25026Q0379 0004.docx Download

Restricted: Unreadable

Summary

Document is unreadable/unextracted (metadata-only). Filename indicates this is amendment 0004 for solicitation 36C25026Q0379, but the file content was not available for review and no substantive text could be verified.

  • Filename: '36C25026Q0379 0004.docx' — implies amendment #0004 for solicitation 36C25026Q0379
  • Extraction status: pending; processing_mode: metadata_only — no content extracted
  • Review status: restricted; limitation_reason: unreadable — cannot access sections or text
  • Opportunity-level facts (from workspace metadata, not the file): Solicitation 36C25026Q0379 titled 'L076--VISN 10 - Online Clinical Drug Information'
  • Set-aside: SDVOSBC (Service-Disabled Veteran-Owned Small Business)
  • NAICS: 513210 (likely IT-related content/online clinical information)
  • Response deadline: 2026-04-08, 1:30 PM EST (quote submission deadline)
  • Place of performance noted as VA Medical Centers across VISN 10 (facilities in Indiana, Michigan, and Ohio)
  • Agency: Department of Veterans Affairs — Network Contract Office 10 (36C250)
  • Inventory metadata flags a Q&A/amendment context in the opportunity description (amendment addressing industry questions and bed-count clarification)
36C25026Q0379.docx Download

Partially reviewed: Too large

Summary

Partial extraction (sections 1 and 4 of 6 only) of the VISN 10 Online Clinical Drug Information RFQ; includes general info, PWS overview, mandatory functional requirements for a commercial online drug reference, subscription pricing CLINs, POP (base + 4 options), security/508 guidance, and VA FAR/VAAR clauses including SDVOSB subcontracting limits. Review is partial due to a large original file; additional sections (e.g., full evaluation/contracting instructions, attachments) were not provided.

  • Agency / buyer: Department of Veterans Affairs, Network Contracting Office 10 (VISN 10) — VISN covers IN, MI, OH; ~685,000 veterans in region (PWS stat).
  • Set-aside: SDVOSB total set-aside (Service-Disabled Veteran-Owned Small Business) — prime must be SDVOSB; VA limitation on subcontracting for services (≤50% to non-certified firms).
  • NAICS / PSC: NAICS 513210 (Software Publishers); PSC L076 (Technical Representative - Books/Maps/Publications).
  • Place of Performance: VISN 10 VA Medical Centers and CBOCs across Indiana, Michigan, and Ohio; services performed at contractor site with remote VA/non‑VA access.
  • Period of Performance: Base 15 Jul 2026–14 Jul 2027 with four 12-month options through 14 Jul 2031 (monthly invoicing).
  • Scope: Subscription access to a comprehensive, evidence‑based online clinical drug reference for pharmacy staff (24/7 access, desktops/laptops/mobile iOS & Android).
  • Technical requirements emphasize clinical content depth: medication monographs, BBWs, REMS, off‑label evidence, pregnancy/lactation, hazardous drug (NIOSH/USP <800>), drug interactions, IV compatibility (e.g., Trissel’s), clinical calculators, medication ID, patient education, comparative tables, ISMP linkage.
  • Performance metrics: 99% uptime (excl. scheduled maintenance) and search results within 2 seconds under standard conditions; clinical updates aligned to authoritative sources (FDA, peer‑reviewed literature).
  • Security / data: ATO not required; no VA PII/PHI stored/processed; contractor to maintain commercially reasonable protections (SOC2/ISO suggested).
  • Accessibility: Section 508 compliance required; VPAT/ACR must be provided.
  • Contracting details: RFQ via FAR 12.6 streamlined commercial items; monthly invoicing, CLIN structure for base + each option; Government may add/remove facilities or users and may increase total contract value up to 20% of base award.
  • Subcontracting constraint: VAAR clause requires offeror certification to meet SDVOSB limitations on subcontracting — important compliance blocker for non‑SDVOSB primes like Trace (per company profile).
  • Response / Q&A: Selected section shows a Q&A period and response deadline (section shows 04-01-2026 13:30 ET) — metadata indicates later amendment; review is partial so date discrepancies should be validated against full solicitation.
Technical details

Entry: sync

Review status: Up to date

Logical upstream opportunity: 1211

Notice lineage:

  • da1618ea5882475e8fa85e550b87bc3f (posted 2026-03-30) - current
  • 11c5735d91244591ba3b832cb05936ed
  • 4e81d7b4c55b44e28380111626a29b59
  • 7187992288594ed69ec4a7c5e6a458bd
  • a3590bdcaf2c432cb895bf6b2e8f5a60

Last synced: 2026-03-31T11:27:55.893818+00:00

Last analyzed: 2026-03-30T18:48:46.747963+00:00

Latest package fingerprint: db84769bb72d46b589144b3868c14ea66143dab728b841c9198b29e4f4209570

Latest package notice: da1618ea5882475e8fa85e550b87bc3f

Latest package documents: 6

Evidence limitations
  • 36C25026Q0379 0004.docx: restricted (unreadable)
  • 36C25026Q0379.docx: partially reviewed (too large)
  • Only partial document evidence was available from the upstream package.
Recent package history
  • 2026-03-30T18:45:53.310050+00:00: da1618ea5882475e8fa85e550b87bc3f with 6 docs

Labels

Human notes

No human notes yet.

Qualification Settings

Included notice types

Scope Filters

Use one code or phrase per line, or comma-separate.

System Settings

Runtime

Custom Search

Search time

These filters apply only to this run. Qualification settings stay unchanged.

Custom Search queries Fetchmesh and stores the results in Scout without mutating the default sync configuration.

Workspace visibility

All custom searches are public for now.

Included notice types

Scope Filters

Use one code or phrase per line, or comma-separate.

Browse Searches